Our History & Milestones
Discover the Ferring story
The development of Ferring is the story of people and peptides. It is about the far-reaching vision of groundbreaking scientists to harness the fundamental role of peptide hormones in controlling many of the body’s key processes to develop medicine on the body’s own terms. And, it is about the vision of entrepreneurs with a spirit of adventure to make these medicines available throughout the globe.
Ferring breaks the ground for the building of its new state-of-the-art multi-purpose site in Saint-Prex, Switzerland and thereby continues its commitment to the region.
On January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed by the renowned architect Henning Larsen, the new building is a landmark for Ferring and one of the highest office buildings in Scandinavia.
In 2000, Ferring launched its latest medicine, TRACTOCILE® (atosiban), a new chemical entity developed by Ferring’s researchers for the treatment of pre-term (premature) labour. Ferring also launched MENOPUR® (menotropin), a follow-up compound to MENOGON® (menotropin) for the treatment of infertile couples.
Dr. Frederik Paulsen, Ferring’s founder, died at the age of 88, after having spent his last 17 years on his native island Föhr together with his wife Eva Paulsen. During these years he was actively involved in Friesian affairs and the problems of minority groups.